312 research outputs found
Importância das Células Tronco Mesenquimais no desenvolvimento do câncer de mama
La mayoría de las pacientes con cáncer de mama (PCM) avanzado desarrollan metástasis óseas, de tipo osteolíticas, como resultado de un desbalance entre los procesos de os-teogénesis, osteoclastogénesis y resorción ósea. Nosotros encontramos en la médula ósea (MO) de las PCM avanzado (carcinoma mamario ductal infiltrante, estadío clínico III y IV, sin metástasis en MO y hueso) una disminución de la eficiencia de clonado de las células madre mesenquimales (MSC), medida como el número de unidades formadoras de colonias fibroblásticas (CFU-F), así como una disminución en su capacidad de diferenciación osteogénica en comparación con las voluntarias sanas (VS). Además, observamos osteoclastogénesis espontánea en MO y sangre periférica de las PCM, mientras que no lo hicimos en las VS. Por último, consideramos importante la evaluación de la diferenciación osteogénica de las MSC de MO y del potencial osteoclasto-génico de los progenitores hematopoyéticos de MO y de los monocitos de sangre periférica, como posibles factores pronósticos de futuros desórdenes óseos que pueden favorecer la invasión de las células del CM en el hueso.Most advanced breast cancer patients (BCP) develop oste-olytic bone metastasis as a result of the imbalance between osteogenesis, osteoclastogenesis and bone resorption processes.In bone marrow (BM) aspirates of untreated BCP (infiltrative ductal breast carcinoma, clinical stage III and IV, without bone and BM metastasis), a decrease in cloning efficiency of BM-mesenchymal stem cells (MSC), measured as number of colony forming unit-fibroblasts (CFU-F), and a decrease in its osteogenic differentiation capacity compared to healthy volunteers (HV) were found . Moreover, spontaneous osteoclastogenesis (SpOC) in BM and peripheral blood of BCP were observed, while SpOC was not observed in BM of HV. Finally, evaluation of the osteogenic differentiation of BM-MSC and osteoclastogenic potential of BM-hematopoi-etic progenitors as well as peripheral blood-monocytes are considered important as possible prognostic factors for future bone disorders that may favor the invasion of BC cells into bone.A maior parte das pacientes com câncer de mama (PCM) avançado desenvolve metástases ósseas, de tipo osteolíticas, como resultado de um desequilíbrio entre os processos de os-teogênese, osteoclastogênese e ressorção óssea. Nós encontramos na medula óssea (MO) das PCM avançado (carcinoma mamário ductal infiltrante, estágío clínico III e IV, sem metástase em MO e osso) uma diminuição da eficiên-cia de clonagem das células tronco mesenquimais (MSC), medida como o número de unidades formadoras de colônias fibroblásticas (CFU-F), bem como uma diminuição em sua capacidade de diferenciação osteogênica em comparação com as voluntárias saudáveis (VS). Além disso, observamos osteoclastogênese espontânea em MO e sangue periférica das PCM, enquanto que não o fizemos nas VS. Por último, consideramos importante a avaliação da diferenciação os-teogênica das MSC de MO e do potencial osteoclastogênico dos progenitores hematopoiéticos de MO e dos monócitos de sangue periférico, como possíveis fatores prognósticos de futuras desordens ósseas que possam favorecer a invasão das células do CM no osso.Fil: Fernández Vallone, Valeria Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); ArgentinaFil: Labovsky, Vivian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); ArgentinaFil: Martinez, Leandro Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); ArgentinaFil: Chasseing, Norma Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentin
Synthesis and magnetic properties of cobalt-iron/cobalt-ferrite soft/hard magnetic core/shell nanowires
A straightforward method for the synthesis of CoFe2.7/CoFe2O4 core/shell nanowires is described. The proposed method starts with a conventional pulsed electrodeposition procedure on alumina nanoporous template. The obtained CoFe2.7 nanowires are released from the template and allowed to oxidize at room conditions over several weeks. The effects of partial oxidation on the structural and magnetic properties were studied by x-ray spectrometry, magnetometry, and scanning and transmission electron microscopy. The results indicate that the final nanowires are composed of 5 nm iron-cobalt alloy nanoparticles. Releasing the nanowires at room conditions promoted surface oxidation of the nanoparticles and created a CoFe2O4 shell spinel-like structure. The shell avoids internal oxidation and promotes the formation of bi-magnetic soft/hard magnetic core/shell nanowires. The magnetic properties of both the initial single-phase CoFe2.7 nanowires and the final core/shell nanowires, reveal that the changes in the properties from the array are due to the oxidation more than effects associated with released processes (disorder and agglomeration).Fil: Londoño Calderon, Cesar Leandro. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Tecnología en Polímeros y Nanotecnología. Universidad de Buenos Aires. Facultad de Ingeniería. Instituto de Tecnología en Polímeros y Nanotecnología; ArgentinaFil: Moscoso Londoño, Oscar. Universidade Estadual de Campinas; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Muraca, Diego. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidade Estadual de Campinas; Brasil. Brazilian Center for Research in Energy and Materials. Brazilian Nanotechnology National Laboratory; BrasilFil: Arzuza, Luis. Universidade Estadual de Campinas; BrasilFil: Carvalho, Peterson. Universidade Estadual de Campinas; BrasilFil: Pirota, Kleber Roberto. Universidade Estadual de Campinas; BrasilFil: Knobel, Marcelo. Universidade Estadual de Campinas; BrasilFil: Pampillo, Laura Gabriela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Tecnologías y Ciencias de la Ingeniería "Hilario Fernández Long". Universidad de Buenos Aires. Facultad de Ingeniería. Instituto de Tecnologías y Ciencias de la Ingeniería "Hilario Fernández Long"; ArgentinaFil: Martinez Garcia, Ricardo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Formosa. Facultad de Recursos Naturales; Argentin
Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer
Tumor epithelial cells (TEpCs) and spindle-shaped stromal cells, not associated with the vasculature, of patients with early breast cancer express osteoprotegerin (OPG), tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), receptor activator of nuclear factor kappa B ligand, stromal cell derived factor-1, interleukin-6, macrophage colony stimulating factor, chemokine (C-C motif) ligand-2 (CCL-2) and their receptors at significantly higher levels compared with non-neoplastic breast tissues. We evaluated the clinicopathological significance of these ligands and receptors in TEpC and spindle-shaped stromal cells, not associated with the vasculature, to determine their impact on prognosis of patients with early-stage breast cancer.Fil: Labovsky, Vivian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Martinez, Leandro Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Davies, Kevin Mauro. Hospital Italiano; ArgentinaFil: de Luján Calcagno, María. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; ArgentinaFil: García Rivello, Hernán. Hospital Italiano; ArgentinaFil: Wernicke, Alejandra. Hospital Italiano; ArgentinaFil: Feldman, Leonardo. Fundación Favaloro; ArgentinaFil: Matas, Ayelen. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; ArgentinaFil: Giorello, María Belén. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; ArgentinaFil: Borzone, Francisco Raúl. Ministerio de Salud. Instituto Nacional del Cancer; ArgentinaFil: Choi, Hosoon. Central Texas Veterans Research Foundation; Estados UnidosFil: Howard, Scott C.. University of Tennessee; Estados UnidosFil: Chasseing, Norma Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentin
Biomarkers of proliferation, survival, and migration of human breast tumor cells: future perspectives
Despite recent major advance in the understanding of the mechanisms of breast cancer (BC) progression and in the development of novel therapeutic modalities, BC remains the second leading cause of mortality among women. Mortality is almost invariably due to metastasis. The different histological subtypes of BC and molecular maker expression (ER, PR and HER2) have strong prognostic and predictive values but are not enough to prevent that BC patients (BCP) develop a relapse and metastasis. So the aim of this work was the simultaneous evaluation of the expression of biomarkers related to BC progression and metastasis (OPG, TRAIL, TRAIL receptores (R) [R1, R2, R3 y R4], RANKL, RANK (RANKL-R), SDF-1, CXCR-4 (SDF-1-R), IL-6, IL-6-R, MCSF and M-CSF-R in BC cells together with the study of classic prognostic parameters (age, ER, PR, HER2, tumor size and histological grade) in BCP. Regarding the expression of these biomarkers in BC cells, the results are contradictory.Fil: Labovsky, Vivian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Martinez, Leandro Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Calcagno, María. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; ArgentinaFil: Davies, Kevin. Hospital Italiano de La Plata; ArgentinaFil: Wenicke, Alejandra. Hospital Italiano; ArgentinaFil: Garcia Rivello, Hernan. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; ArgentinaFil: Fernández Vallone, Valeria Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Chasseing, Norma Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaProceedings of the AACR Special Conference on Tumor Invasion and MetastasisPhiladelphiaEstados UnidosAmerican Association for Cancer Researc
Transcriptomic Profiling of Fibropapillomatosis in Green Sea Turtles (Chelonia mydas) From South Texas
Sea turtle fibropapillomatosis (FP) is a tumor promoting disease that is one of several threats globally to endangered sea turtle populations. The prevalence of FP is highest in green sea turtle (Chelonia mydas) populations, and historically has shown considerable temporal growth. FP tumors can significantly affect the ability of turtles to forage for food and avoid predation and can grow to debilitating sizes. In the current study, based in South Texas, we have applied transcriptome sequencing to FP tumors and healthy control tissue to study the gene expression profiles of FP. By identifying differentially expressed turtle genes in FP, and matching these genes to their closest human ortholog we draw on the wealth of human based knowledge, specifically human cancer, to identify new insights into the biology of sea turtle FP. We show that several genes aberrantly expressed in FP tumors have known tumor promoting biology in humans, including CTHRC1 and NLRC5, and provide support that disruption of the Wnt signaling pathway is a feature of FP. Further, we profiled the expression of current targets of immune checkpoint inhibitors from human oncology in FP tumors and identified potential candidates for future studies
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
Introduction: Osteolytic bone metastasis in advanced breast cancer stages are a major complication for patient ' s quality life and a sign of low survival prognosis. Permissive microenvironments which allow cancer cell secondary homing and later proliferation are fundamental for metastatic processes. The causes and mechanisms behind bone metastasis in breast cancer patients are still an unsolved puzzle. Therefore, in this work we contribute to describe bone marrow pre-metastatic niche in advanced breast cancer patients.
Results: We show an increase in osteoclasts precursors with a concomitant imbalance towards spontaneous osteoclastogenesis which can be evidenced at bone marrow and peripheral levels. Pro-osteoclastogenic factors RANKL and CCL-2 may contribute to bone resorption signature observed in bone marrow. Meanwhile, expression levels of specific microRNAs in primary breast tumors may already indicate a pro-osteoclastogenic scenario prior to bone metastasis.
Discussion: The discovery of prognostic biomarkers and novel therapeutic targets linked to bone metastasis initiation and development are a promising perspective for preventive treatments and metastasis management in advanced breast cancer patients
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
Introduction: Osteolytic bone metastasis in advanced breast cancer stages are a major complication for patient´s quality life and a sign of low survival prognosis. Permissive microenvironments which allow cancer cell secondary homing and later proliferation are fundamental for metastatic processes. The causes and mechanisms behind bone metastasis in breast cancer patients are still an unsolved puzzle. Therefore, in this work we contribute to describe bone marrow pre-metastatic niche in advanced breast cancer patients. Results: We show an increase in osteoclasts precursors with a concomitant imbalance towards spontaneous osteoclastogenesis which can be evidenced at bone marrow and peripheral levels. Pro-osteoclastogenic factors RANKL and CCL-2 may contribute to bone resorption signature observed in bone marrow. Meanwhile, expression levels of specific microRNAs in primary breast tumors may already indicate a pro-osteoclastogenic scenario prior to bone metastasis. Discussion: The discovery of prognostic biomarkers and novel therapeutic targets linked to bone metastasis initiation and development are a promising perspective for preventive treatments and metastasis management in advanced breast cancer patients.Fil: Fernández Vallone, Valeria Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Borzone, Francisco Raúl. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Martinez, Leandro Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Giorello, Maria Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Choi, Hosoon. No especifíca;Fil: Dimase, Federico. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; ArgentinaFil: Feldman, Leonardo. Universidad Nacional del Centro de la Provincia de Buenos Aires; ArgentinaFil: Bordenave, Raúl Horacio. Hospital Iriarte; ArgentinaFil: Chudzinski Tavassi, Ana Marisa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Batagelj, Emilio. Ministerio de Defensa. Ejército Argentino. Hospital Militar Central Cirujano Mayor "Dr. Cosme Argerich"; ArgentinaFil: Chasseing, Norma Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentin
CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients
Introduction: Bone metastasis is one of the causes that mainly decrease survival in patients with advanced breast cancer. Therefore, it is essential to find prognostic markers for the occurrence of this type of metastasis during the early stage of the disease. Currently, cancer-associated fibroblasts, which represent 80% of the fibroblasts present in the tumor microenvironment, are an interesting target for studying new biomarkers and developing alternative therapies. This study evaluated the prognostic significance of the CD105 expression in cancer-associated fibroblasts in early breast cancer patients. Methods: Immunohistochemistry was used to assess CD105 expression in invasive ductal breast carcinomas (n = 342), analyzing its association with clinical and pathological characteristics. Results: High CD105 expression in cancer-associated fibroblasts was associated with an increased risk of metastatic occurrence (p = 0.0003), particularly bone metastasis (p = 0.0005). Furthermore, high CD105 expression was associated with shorter metastasis-free survival, bone metastasis-free survival, and overall survival (p = 0.0002, 0.0006, and 0.0002, respectively). CD105 expression also constituted an independent prognostic factor for metastasis-free survival, bone metastasis-free survival, and overall survival (p = 0.0003, 0.0006, and 0.0001, respectively). Discussion: The high CD105 expression in cancer-associated fibroblasts is an independent prognostic marker for bone metastasis in early breast cancer patients. Therefore, the evaluation of CD105(+) CAFs could be crucial to stratify BCPs based on their individual risk profile for the development of BM, enhancing treatment strategies and outcomes.Fil: Giorello, Maria Belen. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Martinez, Leandro Marcelo. Cornell University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Borzone, Francisco Raúl. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Padin, María del Rosario. Hospital Italiano; ArgentinaFil: Mora, María Florencia. Hospital Italiano; ArgentinaFil: Sevic, Ina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires. Universidad Nacional del Noroeste de la Provincia de Buenos Aires. Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires; ArgentinaFil: Alaniz, Laura Daniela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires. Universidad Nacional del Noroeste de la Provincia de Buenos Aires. Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires; ArgentinaFil: Calcagno, María de Luján. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; ArgentinaFil: Garcia Rivello, Hernan Jorge. Hospital Italiano; ArgentinaFil: Wernicke, Alejandra. Hospital Italiano; ArgentinaFil: Labovsky, Vivian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Chasseing, Norma Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentin
The neural mobilization technique modulates the expression of endogenous opioids in the periaqueductal gray and improves muscle strength and mobility in rats with neuropathic pain
Background\ud
The neural mobilization (NM) technique is a noninvasive method that has been proven to be clinically effective in reducing pain; however, the molecular mechanisms involved remain poorly understood. The aim of this study was to analyze whether NM alters the expression of the mu-opioid receptor (MOR), the delta-opioid receptor (DOR) and the Kappa-opioid receptor (KOR) in the periaqueductal gray (PAG) and improves locomotion and muscle force after chronic constriction injury (CCI) in rats.\ud
\ud
\ud
Methods\ud
The CCI was imposed on adult male rats followed by 10 sessions of NM every other day, starting 14 days after the CCI injury. At the end of the sessions, the PAG was analyzed using Western blot assays for opioid receptors. Locomotion was analyzed by the Sciatic functional index (SFI), and muscle force was analyzed by the BIOPAC system.\ud
\ud
\ud
Results\ud
An improvement in locomotion was observed in animals treated with NM compared with injured animals. Animals treated with NM showed an increase in maximal tetanic force of the tibialis anterior muscle of 172% (p < 0.001) compared with the CCI group. We also observed a decrease of 53% (p < 0.001) and 23% (p < 0.05) in DOR and KOR levels, respectively, after CCI injury compared to those from naive animals and an increase of 17% (p < 0.05) in KOR expression only after NM treatment compared to naive animals. There were no significant changes in MOR expression in the PAG.\ud
\ud
\ud
Conclusion\ud
These data provide evidence that a non-pharmacological NM technique facilitates pain relief by endogenous analgesic modulation.FAPESP [2010/20026-6;2010/52520-0;2012/05840-4; 2012/24408-6]CAPE
Distribución natural de Nothofagus alpina y Nothofagus obliqua (nothofagaceae) en Argentina, dos especies de primera importancia forestal de los bosques templados norpatagónicos
Conocer la distribución natural de cualquier especie es esencial para poder planificar su conservación o uso. El Raulí [Nothofagus alpina (Poepp. & Endl.) Oerst. = Nothofagus nervosa (Phil.) Dim. et Mil.] y el Roble Pellín [Nothofagus obliqua (Mirb.) Oerst. ssp. obliqua] son dos especies forestales de primera importancia en los bosques norpatagónicos, y objetos de un programa de domesticación en curso. En base al cruce de capas de información digital de estudios previos verificada por informantes locales calificados, por controles de campo y por interpretación sobre pantalla de imágenes provistas libremente por Google Earth, se mapeó la distribución natural de ambas especies en Argentina. La presencia del Raulí se registra sobre una superficie de 79.636 ha, mientras que sobre 33.859 ha se desarrollan bosques con presencia de Roble Pellín. La mayor parte de estas superficies se encuentran protegidas por el sistema de Parques Nacionales (97 % del área ocupada con Raulí y 83 % de la ocupada con Roble Pellín), sin embargo varios bosques relevantes para la conservación se hallan bajo jurisdicción de la Provincia de Neuquén, lo cual debería ser considerado al momento de planear una estrategia de conservación para ambas especies.Knowing the natural range of any species is essential to plan its conservation or use. The South-American beeches Raulí [Nothofagus alpina (Poepp. & Endl.) Oerst. = Nothofagus nervosa (Phil.) Dim. et Mil.] and Roble Pellín [Nothofagus obliqua (Mirb.) Oerst. ssp. obliqua] are two important forest tree species of the North Patagonian forests, and the object of a current domestication program. Natural distribution of both beeches in Argentina was mapped based on digital information of previous works which was verified by local qualified informants, ground control check and visual interpretation of images freely provided by Google Earth. Raulí is present over a surface of 79,636 ha, while 33,859 ha are occupied by forests with the presence of Roble Pellín. 97 % of the Raulí and 83 % of the Roble Pellín surfaces are under the protection of the National Park Administration. However, many forests of particular conservation relevance are under the Neuquén Province jurisdiction, what should be considered when planning a conservation strategy for both species.EEA BarilocheFil: Sabatier, Yamila. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Laboratorio de Teledetección; ArgentinaFil: Azpilicueta, Maria Marta. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Unidad de Genética Ecológica y Mejoramiento Forestal; ArgentinaFil: Marchelli, Paula. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Unidad de Genética Ecológica y Mejoramiento Forestal; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: González Peñalba, Marcelo. Parque Nacional Lanín. Departamento de Conservación y Manejo. Área Forestal Técnica; ArgentinaFil: Lozano, Liliana. Parque Nacional Lanín. Departamento de Conservación y Manejo. Área Forestal Técnica; ArgentinaFil: García, Leandro. Parque Nacional Lanín. Departamento de Conservación y Manejo. Área Forestal Técnica; ArgentinaFil: Martinez, Abel Hector Maria. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Unidad de Genética Ecológica y Mejoramiento Forestal; ArgentinaFil: Gallo, Leonardo Ariel. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Unidad de Genética Ecológica y Mejoramiento Forestal; Argentina.Fil: Umaña, Fernando. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Laboratorio de Teledetección; ArgentinaFil: Bran, Donaldo Eduardo. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Laboratorio de Teledetección; ArgentinaFil: Pastorino, Mario Juan. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Bariloche. Unidad de Genética Ecológica y Mejoramiento Forestal; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin
- …